Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Shiro, Imai"'
Autor:
Marika, Sakamoto, Yoshinori, Nio, Shiro, Imai, Takashi, Sakamoto, Masako, Kamei, Mikako, Tamaoki, Masashi, Tamaoki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(3)
The present study reviewed 9 cases of pregnancy and delivery after breast cancer in our clinic, between 2007 and 2019, to evaluate treatment options for their safe and successful management. The mean age at primary surgery was 31.7 years(27- 37); the
Autor:
Takashi, Sakamoto, Yoshinori, Nio, Marika, Sakamoto, Shiro, Imai, Kayo, Uesugi, Mikako, Tamaoki, Masashi, Tamaoki, Riruke, Maruyama
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(8)
Brain metastasis(BM)is the final stage of metastatic breast cancer(MBC), but its course and outcomes after the first metastasis(FM)to various sites are not fully clarified. Furthermore, the survival of patients with BM appears to be improving with th
Autor:
Masashi, Tamaoki, Yoshinori, Nio, Mikako, Tamaoki, Marika, Sakamoto, Kayo, Uesugi, Takashi, Sakamoto, Shiro, Imai, Riruke, Maruyama
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(1)
We report a radiation-associated angiosarcoma(RAAS)of the breast, which is a rare but important complication after breast-conserving surgery(BCS)and radiotherapy(RT)for breast cancer. A7 2-year-old woman had undergone BCS for invasive ductal carcinom
Autor:
Yoshinori, Nio, Shiro, Imai, Marika, Sakamoto, Kayo, Uesugi, Mikako, Tamaoki, Masashi, Tamaoki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(9)
This study compared the treatment results of over 80-year-old(O-80) 54 and 157 septuagenarian(70s)women with breast cancer(BC)from 1996 to 2015, to clarify the best treatment option for O-80BC patients. No differences were observed in the stages and
Autor:
Yuri, Fujimoto, Kazushige, Yamaguchi, Ayako, Ueno, Reo, Sakurai, Yoshio, Nagahisa, Shiro, Imai, Kazuyuki, Kawamoto
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(3)
A 48-year-old woman with severe interstitial pneumonitis was diagnosed with right breast cancer(invasive ductal carcinoma, T1aN1M0, ER+, PgR-, HER2 3+)and underwent modified radical mastectomy.The patient was administered tamoxifen as adjuvant therap
Autor:
Marika, Sakamoto, Yoshinori, Nio, Shiro, Imai, Kayo, Uesugi, Mikako, Tamaoki, Masashi, Tamaoki
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 44(7)
The present study was designed to estimate the clinical efficacy of bevacizumab(BV)combined with paclitaxel(PTX)(BVPTX) as third- and fourth-line therapies in 31 patients with metastatic breast cancer(MBC). Most patients were previously treated with
Autor:
Yasuo Matsutani, Masakazu Toi, Ryuji Okamura, Shiro Imai, Takashi Hashimoto, Akira Yamauchi, Eiji Nakatani, Hirofumi Suwa, You Ichinose, Shigeru Tsuyuki, Hironori Kato, Hiroshi Yoshibayashi, Norimichi Kan, Shunichi Higashide, Fumie Tanaka, Yoshio Moriguchi, Takashi Inamoto, Takashi Okino, Masahiro Takada, Tomika Harada, Ichiro Nakayama, Shingo Sakata, Hiroyasu Yamashiro, Yasuo Wada, Kazuhiko Yamagami
Publikováno v:
International Journal of Clinical Oncology. 19:852-862
Bone metastasis (BM) is important for studying systemic spread of breast cancer. It often causes skeletal-related events (SREs) that worsen quality of life. We investigated the prevalence and risk factors for BM and SRE using a dataset from the Breas
Autor:
Yoshinori, Nio, Shiro, Imai, Kayo, Uesugi, Mikako, Tamaoki, Masashi, Tamaoki, Riruke, Maruyama
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(10)
Triple-negative breast cancers(TNBCs)are associated with early recurrence after surgery and unfavorable prognoses. To date, no effective therapies for TNBCs have been established. The present study was designed to evaluate the efficacy of adjuvant ch
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70:1629-1633
Autor:
Shinichi Hamada, Kenshi Wasada, Masafumi Koga, Sanai Noguchi, Soji Kasayama, Kunihiko Hashimoto, Yasuhiko Morimoto, Shiro Imai, Yuji Murata
Publikováno v:
Diabetes Care
OBJECTIVE—A1C levels have been shown to be elevated in relation to glycemia in late pregnancy, although the precise mechanisms remain undetermined. We hypothesized that iron deficiency is involved in the A1C increase in late pregnancy. RESEARCH DES